Metabolic Syndrome and Kidney Diseases

Vincent Boima; Alexander B. Agyekum; Augustus K. Eduafo

doi:10.1007/978-3-031-40116-9_57

Metabolic Syndrome and Kidney Diseases

Vincent Boima
, Alexander B. Agyekum
, Augustus K. Eduafo

Department of Medicine And Therapeutics

Korle Bu Teaching Hospital
Wright State University

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Citation (Scopus)

Abstract

The metabolic syndrome (MetS) affects 20–25% of people worldwide and increases the risk of cardiovascular disease (CVD). MetS is associated with kidney abnormalities, including activation of the renin-angiotensin-aldosterone system (RAAS), glomerular hyperfiltration, podocyte injury, albuminuria, and fibrosis. This chapter describes the epidemiology and pathogenesis of chronic kidney disease (CKD) in MetS, including the roles of obesity, insulin resistance, diabetes, adipokines, oxidative stress, inflammation, and endothelial dysfunction, and the current and future strategies for prevention and treatment of CKD.

Original language	English
Title of host publication	Metabolic Syndrome
Subtitle of host publication	A Comprehensive Textbook, Second Edition
Publisher	Springer International Publishing
Pages	675-691
Number of pages	17
ISBN (Electronic)	9783031401169
ISBN (Print)	9783031401152
DOIs	https://doi.org/10.1007/978-3-031-40116-9_57
Publication status	Published - 1 Jan 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Albuminuria
Diabetes
Hypertension
Inflammation
Kidney disease
Obesity

Access to Document

10.1007/978-3-031-40116-9_57

Cite this

@inbook{f9fbbea4ddb7407c86945f6f09efee80,

title = "Metabolic Syndrome and Kidney Diseases",

abstract = "The metabolic syndrome (MetS) affects 20–25\% of people worldwide and increases the risk of cardiovascular disease (CVD). MetS is associated with kidney abnormalities, including activation of the renin-angiotensin-aldosterone system (RAAS), glomerular hyperfiltration, podocyte injury, albuminuria, and fibrosis. This chapter describes the epidemiology and pathogenesis of chronic kidney disease (CKD) in MetS, including the roles of obesity, insulin resistance, diabetes, adipokines, oxidative stress, inflammation, and endothelial dysfunction, and the current and future strategies for prevention and treatment of CKD.",

keywords = "Albuminuria, Diabetes, Hypertension, Inflammation, Kidney disease, Obesity",

author = "Vincent Boima and Agyekum, \{Alexander B.\} and Eduafo, \{Augustus K.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2016, 2023.",

year = "2023",

month = jan,

day = "1",

doi = "10.1007/978-3-031-40116-9\_57",

language = "English",

isbn = "9783031401152",

pages = "675--691",

booktitle = "Metabolic Syndrome",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Metabolic Syndrome and Kidney Diseases

AU - Boima, Vincent

AU - Agyekum, Alexander B.

AU - Eduafo, Augustus K.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2016, 2023.

PY - 2023/1/1

Y1 - 2023/1/1

N2 - The metabolic syndrome (MetS) affects 20–25% of people worldwide and increases the risk of cardiovascular disease (CVD). MetS is associated with kidney abnormalities, including activation of the renin-angiotensin-aldosterone system (RAAS), glomerular hyperfiltration, podocyte injury, albuminuria, and fibrosis. This chapter describes the epidemiology and pathogenesis of chronic kidney disease (CKD) in MetS, including the roles of obesity, insulin resistance, diabetes, adipokines, oxidative stress, inflammation, and endothelial dysfunction, and the current and future strategies for prevention and treatment of CKD.

AB - The metabolic syndrome (MetS) affects 20–25% of people worldwide and increases the risk of cardiovascular disease (CVD). MetS is associated with kidney abnormalities, including activation of the renin-angiotensin-aldosterone system (RAAS), glomerular hyperfiltration, podocyte injury, albuminuria, and fibrosis. This chapter describes the epidemiology and pathogenesis of chronic kidney disease (CKD) in MetS, including the roles of obesity, insulin resistance, diabetes, adipokines, oxidative stress, inflammation, and endothelial dysfunction, and the current and future strategies for prevention and treatment of CKD.

KW - Albuminuria

KW - Diabetes

KW - Hypertension

KW - Inflammation

KW - Kidney disease

KW - Obesity

UR - https://www.scopus.com/pages/publications/105004123142

U2 - 10.1007/978-3-031-40116-9_57

DO - 10.1007/978-3-031-40116-9_57

M3 - Chapter

AN - SCOPUS:105004123142

SN - 9783031401152

SP - 675

EP - 691

BT - Metabolic Syndrome

PB - Springer International Publishing

ER -

Metabolic Syndrome and Kidney Diseases

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this